Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 1
2015 2
2016 2
2017 3
2018 3
2019 3
2020 4
2021 5
2022 4
2023 8
2024 2
2025 8
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42 results

Results by year

Filters applied: . Clear all
Page 1
Dual targeting of iNOS and Src tyrosine kinase as a superior therapeutic strategy against soman-induced long-term neurotoxicity: multimodal biomarker, imaging, and neurobehavioral outcome analyses.
Massey N, Vasanthi SS, Meyer C, Rao NS, Thedens DR, Wang C, Kannurpatti S, Thippeswamy T. Massey N, et al. Among authors: thippeswamy t. Acta Neuropathol Commun. 2026 Jan 9;14(1):37. doi: 10.1186/s40478-025-02220-8. Acta Neuropathol Commun. 2026. PMID: 41514296 Free PMC article.
Mitigating organophosphate nerve agent, soman (GD), induced long-term neurotoxicity: Saracatinib, a Src Tyrosine Kinase inhibitor, as a potential countermeasure.
Massey N, Vasanthi SS, Holtkamp C, Meyer C, Rao NS, Gimenez-Lirola LG, Wang C, Im H, Bevoor AS, Kannurpatti S, Thippeswamy T. Massey N, et al. Among authors: thippeswamy t. J Neuroinflammation. 2025 Aug 5;22(1):199. doi: 10.1186/s12974-025-03520-5. J Neuroinflammation. 2025. PMID: 40764938 Free PMC article.
Mitigating Organophosphate Nerve Agent, Soman (GD)-Induced Long-Term Neurotoxicity: Saracatinib, a Src Tyrosine Kinase Inhibitor, as a Potential Countermeasure.
Massey N, Vasanthi SS, Holtkamp C, Meyer C, Rao NS, Gimenez-Lirola LG, Wang C, Im H, Bevoor AS, Kannurpatti S, Thippeswamy T. Massey N, et al. Among authors: thippeswamy t. Res Sq [Preprint]. 2025 Jun 24:rs.3.rs-6674766. doi: 10.21203/rs.3.rs-6674766/v1. Res Sq. 2025. Update in: J Neuroinflammation. 2025 Aug 5;22(1):199. doi: 10.1186/s12974-025-03520-5. PMID: 40678225 Free PMC article. Updated. Preprint.
42 results